⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CMPX News
Compass Therapeutics, Inc. Common Stock
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Compass Therapeutics, Inc. (CMPX) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
CMPX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
accessnewswire.com
CMPX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
prnewswire.com
CMPX
Bronstein, Gewirtz & Grossman, LLC Encourages Compass Therapeutics, Inc. (CMPX) Investors to Inquire about Securities Investigation
accessnewswire.com
CMPX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
accessnewswire.com
CMPX
Compass Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
CMPX
Form 8-K
sec.gov
CMPX
Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
globenewswire.com
CMPX
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
globenewswire.com
CMPX
CMP Pharma Announces Availability of a New Alcohol-Free Reformulation of Norliqva® (Amlodipine) Oral Solution
prnewswire.com
CMPX